Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
NDR Medical Technology’s ANT-X Granted FDA Clearance, Paving the Way for Image-Guided Surgeries
ANT-X is an interventional robot that leverages C-arm fluoroscopy to help clinicians achieve swift and accurate percutaneous needle placement. NDR Medical Technology, an AI-empowered interventional robotics company, today announced that the ANT-X has been granted FDA 510(k) clearance by the U.S. - July 17, 2023 - NDR Medical Technology
Paras Biopharma (Biologics CDMO) Announces Industry Leading Scale-up Development & Production Process of an “Onco-Immunology Fc-fusion Biologic”
Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” biologic. - July 12, 2023 - Paras Biopharmaceuticals Finland Oy
CloudLIMS Exhibits Its Secure Clinical LIMS at the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo
CloudLIMS to showcase its configurable, secure, in-the-cloud Clinical LIMS at booth 4089 during the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo. - July 12, 2023 - CloudLIMS
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics has announced the launch of new reagent solutions for herpesvirus research. - July 07, 2023 - Creative Diagnostics
Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced its membership in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the region's premier trade association for small to medium-sized companies in the pharmaceutical,... - July 05, 2023 - Hemanext
UserWise, LLC Celebrates Role in Norlase Obtaining 510(k) Clearance and CE Mark Approval
UserWise, LLC, a San Jose-based human factors consultancy, is pleased to announce its instrumental role in obtaining FDA 510(k) clearance and CE Mark approval for the Norlase ECHO™ Green Pattern Laser photocoagulator. UserWise began working with Norlase in 2018 to develop and execute the... - June 23, 2023 - UserWise, LLC
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
SunMed Selected to Exhibit SolidAIRity Flex® Oral Endotracheal Tube Stabilization Device at Vizient Innovative Technology Exchange
SunMed has been selected to exhibit the SolidAIRity Flex® Oral Endotracheal Tube Stabilization Device at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine,... - June 10, 2023 - Securisyn Medical
NuvOx Announces Glioblastoma Patient Treatment for Phase IIb RESTORE Trial
NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, announced that it enrolled and treated the first subject in the Phase IIb RESTORE Trial for newly-diagnosed glioblastoma multiforme... - June 09, 2023 - NuvOx Therapeutics
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases. - June 09, 2023 - Creative Diagnostics
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Hemanext Continues European Rollout of Hemanext ONE® RBC Processing and Storage System
Groundbreaking technology to be deployed to transfuse thalassemia patients in Italy and acute bleeding burn patients in Norway. - May 25, 2023 - Hemanext
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
GARM Clinic Introduces GARM Community: a Patient-Centric Initiative to Foster Healthier Living and Stronger Connections
The GARM Clinic, a pioneer in regenerative medicine, proudly announces the launch of the GARM Community, a groundbreaking initiative designed to enhance patient care, create a sense of belonging, and promote healthier living for past, present, and future patients. This innovative program aims to... - May 19, 2023 - GARM Clinic
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
MPFI Researcher Receives Prominent Award to Launch New Lab
The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023 - Max Planck Florida Institute for Neuroscience
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
150 Next-Generation Bionic Arm Prostheses from CF Dopomogator Founded by Olena Chernovolova
Charity foundation Dopomogator (founded by Olena Chernovolova) and Allbionics.io team have announced the launch of a bionic prosthetics project for Ukrainians who have lost limbs during the war. According to the founder of the Found, Olena Chernovolova, the goal of the project is to return adults and children who have become victims of the war to a full life. - May 05, 2023 - Dopomogator
World-Renowned Research Leader Returns as COO of Max Planck Florida Institute for Neuroscience
Max Planck Florida Institute for Neuroscience is pleased to welcome neuroscientist and research infrastructure expert Dr. Ivan Baines back to South Florida as Chief Operating Officer at MPFI. Dr. Baines’ globe-spanning expertise includes work for the U.S. National Institutes of Health; 20 years as COO and Board Member for the Max Planck Institute of Molecular Biology and Genetics in Dresden, Germany, and as a former faculty member for Florida Atlantic University. - May 04, 2023 - Max Planck Florida Institute for Neuroscience
Cyclists Ride Through MA, NH, and ME in Tri-State Trek to Benefit ALS Research
June 24-25, cyclists of all levels are invited to participate in the Tri-State Trek, a New England cycling event raising funds for cutting-edge research to end ALS. - May 03, 2023 - ALS Therapy Development Institute
Maxis Clinical Sciences Expands to UK & Europe, Reinforcing Global Clinical R&D Impact
Bridging the Gap: Maxis Clinical Sciences Unveils Expansion Plans to Drive Innovation and Collaboration in Life Sciences and Healthcare - May 02, 2023 - Maxis Clinical Sciences
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
Fight ALS Film Fest Aims to Continue the Momentum to Beat ALS
The second annual Festival will explore universal themes of life-changing diseases through examination of ALS. - April 26, 2023 - ALS Therapy Development Institute
NuvOx Receives SPAN Grant
NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion - April 24, 2023 - NuvOx Therapeutics
Thrombolex, Inc. Has Received FDA Clearance for Use of BASHIR™ Endovascular Catheters for Treatment of Acute Pulmonary Embolism
Thrombolex, Inc. has received 510(k) clearance for use of the BASHIR™ and BASHIR™ S-B Endovascular Catheters for the treatment of acute pulmonary embolism (PE). - April 20, 2023 - Thrombolex, Inc.
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. - April 20, 2023 - BOC Sciences
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
ProMedix Inc. Awarded Competitive Grant from the U.S. National Science Foundation
ProMedix Inc. has been awarded a U.S. National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $250,000.00 to conduct research and development (R&D) work on improving outcomes from sepsis through active digital monitoring of peripheral blood flow. Impaired... - April 17, 2023 - ProMedix Inc.
Creative Biolabs Provides Full-Fledged Solutions for Progressive Exosome Research
A newly released market research reports on the prosperous future of exosome research. - April 14, 2023 - Creative Biolabs
Black Students in Pittsburgh 3-D Print Living Artery as Part of C-3PO Project
In the C-3PO project of The Citizen Science Lab, African American high school and middle school students have 3-D printed their first living body part. - April 12, 2023 - The Citizen Science Lab
Hemanext Partners with Sickle Cell Disease Association of America and OneBlood to Support Blood Drive in Miami Gardens
NFL Linebacker Markus Golden Joins Forces for an Inspiring #Donate4Diversity Blood Drive on Saturday, April 1, 2023, at Walmart Supercenter Parking Lot, 19501 NW 27th Ave., Miami Gardens, FL - March 30, 2023 - Hemanext
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities. - March 12, 2023 - Creative Diagnostics
NeuroSolution Center of Austin Introduces Innovative Laser Activated PRP Procedure for Restorative Medicine
The NeuroSolution Center of Austin has announced a revolutionary treatment, the Laser Activated Platelet Rich Plasma (PRP) procedure. Developed with the expertise of renowned neurosurgeon Dr. Marcella Madera, the procedure harnesses the regenerative power of PRP, enhanced by laser activation. Suitable for a range of conditions, it offers a natural alternative to traditional medical interventions, and future rounds of the procedure are scheduled for interested individuals. - February 26, 2023 - Neurosolution
FreeLIMS' New Version Augments Productivity & Data Management Capabilities of Labs
The new version of FreeLIMS’ Laboratory Information Management System (LIMS) augments the productivity & data Management capabilities of labs. - February 24, 2023 - FreeLIMS
Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics recently introduced a series of HPV vaccine development products. - February 17, 2023 - Creative Diagnostics
New York Imaging Specialists Names Dr. Matthew Comito Chief Radiology Officer
New York Imaging Specialists is proud to announce that radiologist Matthew Comito, MD, has been appointed Chief Radiology Officer. “Dr. Comito has the administrative, scientific, clinical, leadership, and visionary skills needed to move the Department of Radiology forward,” said Jeff... - February 16, 2023 - New York Imaging Specialists
Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media
Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC
Former FDA Investigator Launches cGMP Quality Systems Certification
With increased actions against pharmaceutical companies, a former FDA Investigator has launched an auditing service to certify any or all of the Quality systems reviewed during FDA inspections. The audits must be on-site and conclude without any Major or Critical observations in order to receive a certificate for the system(s) observed. - February 09, 2023 - FD-AID, LLC
Plus91’s ABDM Compliant MediXcel HIMS Has Successfully Passed QCI and NABH Audits for All Modules
Plus91 receives the official assessment report from QCI and NABH confirming that its Digital Health Platform, MediXcel covers all modules and functions in their checklist. - January 31, 2023 - Plus91 Technologies Pvt Ltd
Genesis AEC Celebrates 25th Anniversary
Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC
Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community
Partnership Will Expand to Include Educational and Donation Event with OneBlood. - January 17, 2023 - Hemanext
Newly Available Horse-Side IgG Test Requires No Refrigeration
VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.
Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers
Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers. - January 06, 2023 - Creative Diagnostics